Showing results (21-30 of 135) with videos related to
Sort By:
Pageof 14
The Journal of Infectious Diseases|November 26, 2013
Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trialLars Toft, Merete Storgaard, Martin Müller, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2006
HIV-1 reverse transcriptase gene 103K/N and 184M/V combinations in tandem: detection and quantification of HIV-1 populations in the CD45RO+ T-cell compartment by a double-ARMS real-time PCR assayRajesh Mohey, Martin Tolstrup, Louise B Jørgensen, et al.Human Vaccines & Immunotherapeutics|February 21, 2014
Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adultsLars Toft, Martin Tolstrup, Martin Müller, et al.AIDS Research and Human Retroviruses|August 8, 2012
Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infectionLine Vibholm, Line S Reinert, Ole S Søgaard, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2010
Transmission of HIV-1 drug-resistant variants: prevalence and effect on treatment outcomeMartin R Jakobsen, Martin Tolstrup, Ole S Søgaard, et al.Journal of Clinical Immunology|December 23, 2025
Signatures of Trained Immunity Following mRNA Vaccination: Differences Between mRNA-1273 and BNT162b2Martin Kunc, Bradley Joseph Whitehead, Lars Jørgen Østergaard, et al.Frontiers in Immunology|December 10, 2021
Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and ThrombosisSisse R Ostrowski, Ole S Søgaard, Martin Tolstrup, et al.Vaccine|February 21, 2016
Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccinesHelena Faust, Lars Toft, Peter Sehr, et al.Journal of Virology|February 19, 2016
A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T CellsRasmus Offersen, Sara Konstantin Nissen, Thomas A Rasmussen, et al.AIDS (London, England)|September 5, 2021
Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral reboundMichael J Corley, Alina P S Pang, Thomas A Rasmussen, et al.Pageof 14